🚦 What are the analysts' short-term price targets for Sana Biotechnology?

The analysts' short-term price targets for Sana Biotechnology (SANA) are as follows:

1. **Citi Analyst**: Citi analyst Samantha Semenkow has set a short-term price target of $15 for Sana Biotechnology. This target is based on the company's potential in addressing notable market opportunities, particularly in the Type 1 Diabetes (T1D) program.
2. **Morgan Stanley Analyst**: Morgan Stanley analyst Maxwell Skor has set a short-term price target of $12 for Sana Biotechnology. This target is based on the analyst's expectations for an investigational new drug filing for SC451 as early as next year.

It's important to note that these short-term price targets are based on analysts' opinions and should not be considered as definitive forecasts of future performance. Other factors such as market conditions, company performance, and industry trends can also impact the stock's trajectory. Additionally, there are no current short-term price targets available from other analysts.